ORIGINAL RESEARCH
Accepted on 19 Mar 2025
Exhaled breath analysis with the use of an electronic nose to predict response to immune checkpoint inhibitors in patients with metastatic melanoma: melaNose trial
doi 10.3389/fimmu.2025.1564463
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Current Insights in Melanoma Immunology, Immune Escape and Immunotherapy Advances
Current Insights in Melanoma Immunology, Immune Escape and Immunotherapy Advances
676
Total downloads
2,560
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
ORIGINAL RESEARCH
Accepted on 10 Mar 2025
Transcriptomic signatures in peripheral CD4 + T-lymphocytes may reflect melanoma staging and immunotherapy responsiveness prior to ICI initiation
doi 10.3389/fimmu.2025.1529707
ORIGINAL RESEARCH
Published on 16 Dec 2024
Impact of steroid-sparing immunosuppressive agents on tumor outcome in the context of cancer immunotherapy with highlight on melanoma: a systematic literature review and meta-analysis
doi 10.3389/fimmu.2024.1499478
- 947 views
CASE REPORT
Published on 26 Nov 2024
Refractory hypokalemia and metabolic acidosis induced by undifferentiated connective tissue disease secondary to immune checkpoint inhibitors: a case report and literature review
doi 10.3389/fonc.2024.1442605
- 607 views
- 1 citation
Published in
Frontiers in Immunology
Cancer Immunity and Immunotherapy
Participating Journals
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
Select the journal/section where you want your idea to be submitted: